Qube Research & Technologies LTD Chimerix Inc Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Chimerix Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 86 shares of CMRX stock, worth $75. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86
Previous 86
-0.0%
Holding current value
$75
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CMRX
# of Institutions
80Shares Held
36.8MCall Options Held
72.2KPut Options Held
169K-
Ra Capital Management, L.P. Boston, MA8.8MShares$7.74 Million0.12% of portfolio
-
Monaco Asset Management Sam4.38MShares$3.85 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.82 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.22MShares$1.96 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$1.91 Million0.01% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $77.1M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...